← Emergent Ventures MODERATE General
Programme Research
Emergent Ventures ·
Programme Site
MEDIUM confidence Researched 2026-07-05 05:07 · profile: researcher
Emergent Ventures, run by economist Tyler Cowen at the Mercatus Center (George Mason University) and seeded by the Thiel Foundation, funds individuals rather than institutions — people Cowen personally believes will produce outsized positive impact for civilisation. It exists as an explicit rejection of conventional grant-making: no committees, no rubrics, no deliverable timelines. Cowen reads applications himself and bets on people whose trajectories he finds unusually promising, with particular interest in those operating outside elite Western institutional pipelines.
• Cowen as sole decision-maker: no scoring rubric exists — he bets on his own judgment, so legibility to a generalist economist-polymath matters more than peer-review framing • High-variance potential: projects that could matter a lot if they work, not projects that are likely to produce modest, safe outputs • Intellectual seriousness and polymathic breadth: Cowen is famous for rewarding people who read and think across domains • Specificity of ask: what exactly will the money do? Vague 'fund my research' proposals lose to concrete plans (buy compute, travel to collaborator, prototype X) • Independence and unconventionality: people who are doing ambitious things outside normal pathways, not waiting for institutional permission • Global development lens: Cowen cares deeply about talent and ideas from the developing world — explicitly funded African and South/Southeast Asian applicants • Speed of execution: evidence you are already doing the work, not planning to start if funded • No formal eligibility gates: no degree requirement, no citizenship restriction, no career-stage cutoff — rolling, open to anyone
Winners skew toward: (1) young independent researchers/builders doing serious work outside academia (or alongside it); (2) writers, journalists, economists with contrarian takes; (3) entrepreneurs at the pre-traction stage building something civilisationally useful; (4) people from developing nations doing high-ambition intellectual or technical work. Named or publicly acknowledged examples include: Shruti Rajagopalan (Indian economist, independent research); various sub-Saharan African writers and policy researchers; multiple young ML/bioinformatics researchers; platform and tool builders in health, education, and finance. The profile is consistently: unusually self-directed, already producing output, low prestige-institution dependency, clear about what they would do with money. Cowen has explicitly used EV to fund 'people, not proposals.'
A 24–35 year old with an unusual intellectual trajectory — pharmacologist turned ML engineer, or philosopher turned mechanism designer — who is already shipping outputs (papers, tools, experiments) without waiting for institutional approval. They have a specific, concrete ask ($30K for compute + travel to three collaborator labs) tied to a project that could matter at civilisational scale if right. They are legible to a smart generalist: able to explain their work's importance in two sentences without jargon, while signalling genuine depth underneath.
Eniola should not lead with 'addiction pharmacology researcher' — he should lead as an independent builder from Lagos who has, without a PhD programme or institutional resources, produced a validated tripartite neuro-pharmacological model, three pre-registered preprints, and three working software platforms. The frame for Cowen is: 'This is what happens when a self-directed polymath from Nigeria decides to do frontier science outside the credentialing system — here is the receipts, here is the specific next step, here is what $X buys.' The CCT model's platform-to-clinic pathway (IMPRINT screening → CCT protocol → TOPOLOGIX safety layer) is the civilisational scaling story; the addiction epidemic in LMICs, where pharmacological treatment infrastructure is near-zero, is the stakes. Eniola should make the ask hyper-concrete: e.g. 'fund six months of compute for Bayesian MCMC at scale + one trip to Berridge/Gershman labs + provisional patent filing costs.'
• The application must not read as an academic grant proposal — Cowen will disengage if it sounds like an NIH specific aims page; must be written as a direct, human pitch to a curious generalist • No institutional affiliation for the research makes the ask slightly harder to anchor — mitigate by leading with the collaborator network (Berridge, Gershman, Daw, Mattar) as the credibility signal • The platforms (IMPRINT, TOPOLOGIX, GATE) need clearer user/adoption numbers or concrete next milestones, otherwise they read as proofs-of-concept rather than things that could scale • ZYCO is not yet explained publicly — the application must briefly clarify what it is so it doesn't appear to be a ghost entity • EV's general track has become more competitive since ~2022; applications from Africa on technical science topics are differentiated but Eniola must avoid the trap of leaning on the 'Africa narrative' as the hook — the science and the build must carry the pitch, with geography as amplifier not lead